Key Takeaways
- Dental practice transitions follow several main paths, including outright sale, associate buy-in, phased partnership, DSO affiliation, work-back arrangements, and mergers. Each path uses different valuation methods, deal structures, and post-close expectations.
- Private buyer sales usually deliver mostly cash at close with short work-backs. DSO deals often include 60–80% cash plus rollover equity and earnouts, so sellers need to understand equity risk and post-close employment terms.
- Practice size and revenue can be some of the main factors that shape the right path. Practices under $1.5M often suit doctor-to-doctor sales, while those over $3M tend to attract DSO interest. Practices in the $1.5–3M range usually benefit from side-by-side valuations.
- Valuation method matters. Private sales often rely on SDE-based methods, while DSOs use EBITDA-based methods. A diligence-grade analysis can reduce retrades and support stronger outcomes in both markets.
- McLerran & Associates provides sell-side-only advocacy, runs both private-buyer and DSO paths, and delivers side-by-side valuations so owners can choose a transition path with fuller information.
Get a side-by-side valuation before you choose a path — start with a confidential call.
The Full Menu Of Dental Practice Transition Options
Dental practice transitions extend beyond the four models most search results describe. The American Dental Association’s “Joining and Leaving the Dental Practice” resource recognizes associate entry, partnership, associate buy-ins, and owner buy-outs as distinct paths, each with its own valuation method, buyer profile, and post-close expectations.
The table below shows how six common paths differ on three practical dimensions: how the practice is valued, how much cash typically arrives at closing, and how long the seller usually keeps working afterward. This comparison helps owners see the tradeoff between cash today, equity and earnouts, and post-close time in the chair.
| Transition Option | Typical Valuation Method | Typical % Of Deal Value Paid As Cash At Close | Typical Post-Close Work Expectation |
|---|---|---|---|
| Outright sale to a private buyer (doctor-to-doctor walk-away) | Percentage of revenue or multiple of net cash flow (SDE); doctor-to-doctor sales typically clear at a percentage of net revenue | 80–100%; seller financing or SBA-backed buyer note common | Short work-back, typically 4–8 weeks, then full exit |
| Associate-to-owner transition (associate buys in over time) | Income approach (multiple of EBITDA or SDE) at each tranche; valuation method should be specified upfront in the agreement | 40–60%; mix of bank financing, seller note, and earnings holdback | Seller typically remains active through the full buy-in period, which commonly runs 3–7 years (with some structures extending to 4–7 years) |
| Phased buy-in / partnership vest-out (sell ~50% now, remainder vests over time) | Income approach on fractional share; partnership buy-ins often apply a minority interest discount to the fractional share | 50% at first tranche; remainder paid as additional tranches close | Seller continues as active partner through vest-out period |
| DSO or private equity affiliation | Multiple of adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization, which is a measure of true operating profit); practice-level multiples have held within a general range over the past two years | 60–80%; remainder in rollover equity and/or earnout | Minimum 5-year working agreement is typical; more DSOs now require a minimum 5-year post-close employment term |
| Sell-now-practice-part-time (work-back arrangement) | Same as outright or DSO sale depending on buyer; post-close schedule negotiated separately | Varies (mirrors underlying path) | Seller continues part-time on a negotiated schedule; in DSO affiliations, the selling dentist usually remains involved under a typical minimum five-year working agreement, though a shorter work-back may be possible if they have already worked themselves mostly out of the chair |
| Merger with another practice | Combined income approach; each practice valued independently, then merged entity valued for synergies | Deal-specific; often an equity exchange or cash-and-equity combination | Both owners typically remain active through integration period |
For a deeper look at how partnership structures can serve as a retirement bridge, see McLerran & Associates’ guide to dental partnership options to transition into retirement.
How To Choose Between A Private Sale And A DSO
Of the paths above, selling to a private buyer and affiliating with a DSO account for many transitions. These two routes differ structurally in ways that extend well beyond the headline price, so a clear comparison can help owners decide.
Valuation methods diverge. A doctor-to-doctor sale typically values the practice as a percentage of revenue or a multiple of net cash flow. This method aligns with what an individual buyer can finance through an SBA loan or conventional lending. A DSO or private equity affiliation values the practice as a multiple of adjusted EBITDA. Because EBITDA normalizes for the owner’s compensation and personal expenses, the same practice can produce a very different value depending on which method applies. Practices with under $500K adjusted EBITDA typically sell doctor-to-doctor at a percentage of collections, while DSOs rarely engage below a certain post-doctor-comp EBITDA threshold.
Deal structure differs significantly. A private walk-away sale usually delivers mostly cash at close, with a short 4–8-week work-back and a clean exit. A DSO deal is a more complex instrument. Most dental and medical practice transactions divide total consideration into three components: cash at closing, rollover equity, and earnout payments. As much as 40% of a DSO deal can be paid in equity rather than cash, which means the seller becomes a seller, a partner, and an investor in the acquiring organization at the same time.
Equity structure shapes risk and upside. Rollover equity, which is the ownership stake a seller retains in the acquiring platform, can sit at two levels. Joint-venture-level equity sits at the individual practice level and typically generates distributions, which creates a higher floor and a lower ceiling. Holding-company equity sits at the parent DSO level, generates no distributions during the hold period, and can multiply several times over if the DSO recapitalizes at a higher multiple. Rollover equity in a DSO transaction defers gain on that portion, which can create a potential “second bite” when the DSO is eventually acquired or recapitalized, often within 3–7 years. Knowing which type of equity is on the table, and reviewing the DSO’s financial health before accepting it, is a central part of evaluating any DSO offer.
Clinical autonomy and post-close life differ. In a private doctor-to-doctor sale, the seller exits. In a DSO affiliation, the seller often continues clinical production as an employee or minority partner of the acquiring organization. The DSO usually takes over the business side: payroll, HR, fee schedules, payer contracting, supply ordering, and marketing. In most DSO transactions, clinical autonomy is preserved in the sense that treatment planning decisions and clinical protocols remain the responsibility of the treating dentist, while the management service agreement assigns non-clinical functions to the DSO. The degree to which that arrangement holds in practice depends heavily on which DSO is the buyer.
Earnout risk is real. An earnout is a contingent payment made after closing if the practice meets specified financial targets, such as revenue, EBITDA, or collections, over a defined measurement period. Earnout structures where the buyer controls expenses, headcount, and pricing post-close may be structurally difficult to achieve regardless of the seller’s clinical performance. Negotiating non-punitive earnout terms, such as pro-rata provisions that pay most of the earnout even on a near-miss, can be a meaningful part of protecting the seller’s total economic outcome.
Because McLerran & Associates works both paths in roughly equal measure, the firm can produce a side-by-side valuation that quantifies the practice’s worth in both the private-buyer and DSO markets. Owners then see a real comparison instead of a guess. For more on how to select the right advisor for this process, see the firm’s guide to choosing the best dental practice broker.
Find out what your practice is really worth — request a detailed practice valuation.
How Practice Size, Timeline, Goals, And Specialty Shape Your Options
Practice size, transition timeline, personal goals, and specialty can be some of the main variables that point toward the right dental practice transition option. The framework below connects each factor to likely paths.
Practice size and revenue. Smaller premier practices, roughly $1–1.5M in annual revenue, often fit a doctor-to-doctor sale best because individual buyers can finance the acquisition through SBA lending and the practice’s cash flow can service the debt. The largest practices, those generating $3M or more, often point toward the DSO path. Platform and portfolio DSOs targeting practices with $1.5M or more in collections have competed aggressively for mid-career practitioners since 2018. Owners in the $1.5–3M revenue range occupy a genuine middle ground. They can attract both private buyers and DSO interest and usually benefit from a side-by-side valuation that quantifies the difference.
Timeline. Owners who are 2–5 years from an exit often benefit from starting with valuation and education instead of a listing. Dental practice owners who begin transition planning 5 to 10 years before a target exit can achieve higher realized values and smoother patient handoffs than those who begin within 3 years of exit. Beginning early tends to create options, while beginning late can compress them.
Personal “why.” Most sellers have a specific reason driving the conversation. Some want help with employees, infrastructure, spending, or growth. Others want to take chips off the table while continuing to practice. Many are planning an eventual full exit. That “why” shapes the path. An owner who wants operational support and continued clinical involvement is a different candidate than one who wants a clean walk-away. McLerran & Associates’ first job is to understand that why before recommending any path.
Specialty. A practice’s specialty influences buyer demand and valuation across both paths. Oral and maxillofacial surgery often commands the highest multiples and remains one of the fastest-consolidating segments, which reflects strong buyer demand. Orthodontics and pediatric dentistry draw strong DSO interest. General dentistry still earns aggressive, near-all-time-high valuations. Lighter-demand specialties such as prosthodontics tend to sit at the lower end of the range. DSOs looking to buy now scrutinize practices’ financials, operations, and projections more intensely because the supply of “premium” practices is tight, so specialty fit and practice quality can matter more than ever.
How To Value A Dental Practice Before Choosing A Transition Path
Valuation often determines much of the outcome in a dental practice transition. The method used, and the rigor behind it, can swing what an owner walks away with by millions of dollars.
Two methods, two markets. For doctor-to-doctor deals, value is typically calculated as a percentage of revenue or a multiple of net cash flow, also called seller’s discretionary earnings, or SDE. SDE is what a single owner-operator earns after adding back their total compensation and personal expenses. For DSO and private equity deals, value is calculated as a multiple of adjusted EBITDA. EBITDA and SDE are different bases. Applying the same multiple to each produces very different numbers, so the earnings base is only as reliable as the normalization behind it.
What a diligence-grade EBITDA analysis involves. A CPA-led EBITDA analysis starts by remotely accessing the practice’s management software, pulling the necessary reports, and cross-referencing the data against the financials. Every discretionary, personal, and non-recurring expense is unpacked to arrive at true operating profitability. The adjustments typically include owner compensation above a market-rate associate replacement salary, personal vehicle and club memberships, family members on payroll at above-market rates, and one-time legal or equipment costs. Not every normalization adjustment helps the seller. Some work against the seller when staffing, compensation, or facility investment has been understated, and unsupported adjustments can collapse once buyers request payroll records, invoices, tax returns, and practice-management reports.
The cost of a “free” valuation. A back-of-the-napkin number set by the buyer often becomes the anchor that determines what the owner walks away with. Aggressive or unsupported add-backs are a leading cause of post-LOI price cuts, or retrades, in dental practice sales. A weak valuation analysis can get picked apart in due diligence, which leads to re-traded deals where the buyer reduces the agreed price after entering exclusivity, when the seller has the least leverage.
How fundamentals influence multiples. Multiples are driven by fundamentals rather than a fixed table. The larger the practice, the more doctors and expandability, the more durable the revenue, and the higher the EBITDA, the higher the multiple a practice can often command. Dental practices with $1M+ EBITDA can attract 3–5 letters of intent simultaneously. This level of interest allows the seller’s advisor to run a true auction and push the multiple toward the upper end of the applicable size band. Presenting ranges and the factors that move them gives owners a realistic way to think about valuation.
McLerran & Associates has evaluated more than 10,000 dental practices and builds a side-by-side valuation for owners weighing both paths, so the comparison rests on real market data instead of a single buyer’s offer.
Request a side-by-side valuation from McLerran & Associates.
What Each Dental Practice Transition Option Nets You Over Time
The headline price tells only part of the story. What the owner actually nets after taxes, deal structure, and time often matters more.
Multi-year, multi-structure forecasting. McLerran & Associates models what each path can net the owner over 3-, 5-, 7-, and 10-year horizons, including conservative recapitalization assumptions. A private-buyer outcome, such as keeping the practice another year and taking distributions, selling half now and half later, or selling outright, is modeled alongside DSO outcomes across the major deal structures, including holding-company, traditional, joint-venture, and hybrid. The option of doing nothing and keeping the practice appears as a baseline for comparison.
Tax treatment matters. In an asset sale of a dental practice, the allocation of the purchase price among asset categories, such as goodwill, tangible assets, and covenants not to compete, determines whether proceeds are taxed as ordinary income or capital gains. The single biggest tax lever in a dental practice sale is the allocation between goodwill, which is taxed at 23.8% federal capital gains plus net investment income tax, and non-compete payments, which are taxed as ordinary income at up to 37%. Much of a DSO deal can qualify for long-term capital gains treatment instead of ordinary income, but the specifics depend on how the deal is structured and allocated. A qualified tax advisor should review the structure before anything is signed.
Equity risk is real. That equity component, which can reach about 40% of deal value as noted earlier, often carries the most uncertainty. Some DSOs promised selling dentists rollover equity returns of three, four, or even five times, but in today’s higher interest-rate environment some DSOs cannot deliver those promised returns. Partnering with an undercapitalized or poorly run DSO can put a large share of the owner’s proceeds at risk, including situations where DSOs later struggle or fall into receivership. Reviewing the DSO like an investment, including its profitability, growth, leadership, and financial backing, becomes part of the deal itself.
The Risks That Derail Dental Practice Transitions
Once owners understand potential upside, the next step is to look at what can go wrong. Dental practice transitions can be fragile. They may collapse at multiple points before closing, and the damage often happens quietly in the valuation, in due diligence, or in a deal structure the seller did not fully understand before signing.
Do-it-yourself close rates are low. Approximately 30% of dental practice transitions occur under urgency conditions such as health events, death, partnership dissolution, or financial distress. These situations compress negotiating room and planning timelines. Even under normal conditions, do-it-yourself close rates can run as low as 15–20%, versus roughly 80% for a well-run brokered process.
Information asymmetry is the central problem. A practice owner usually sells once in a lifetime, while a DSO negotiates deals every week. Most dentists sign only one practice sale agreement in their lifetime, while buyers such as DSOs, PE-backed groups, and other dentists sign dozens. This experience gap can disadvantage sellers in negotiations. An unrepresented dentist negotiating directly with a single DSO often faces a counterparty with far more practice in these deals.
Exposure to one buyer reduces competitive tension. A seller who talks to only one DSO sees only one offer. There is no competitive tension to push the price up and no way to know whether that buyer is even a good fit. Unfocused buyer outreach can create confidentiality risk, confuse the market, and attract buyers that are not capable of closing on acceptable terms.
Retrades are common. Buyer concerns that commonly trigger retrades in dental practice sales include provider concentration, messy financials, short leases, compliance gaps, and credentialing delays. Once a seller enters exclusivity, leverage often shifts to the buyer. Diligence-grade preparation before going to market can be one of the most reliable protections against a re-traded deal.
Representation changes the outcome. McLerran & Associates reports that roughly 85–90% of its clients transact, versus an industry norm closer to 35–40%. Clients typically see around a 30% higher valuation than owners achieve selling on their own. The firm vets buyers like investments and has blacklisted DSOs known for poor post-close environments, so weaker buyers never reach the table. For a detailed comparison of how sell-side advisory differs from traditional brokerage, see sell-side advisor vs. dental practice broker: what differs.
Talk to a dental-only sell-side advisor about your transition options.
How To Prepare Before You Choose A Dental Practice Transition Option
The sequence often matters. Valuation usually comes first, then structure. Owners benefit from knowing what their practice is worth in both markets before deciding on a path, rather than after a buyer has already set the anchor.
Before entering any process, document goals, constraints, risks, and decision criteria. This step matters because a seller who has not defined a minimum acceptable cash-at-close figure, an acceptable post-close work arrangement, and a plan for staff and patients has little mandate to negotiate from once a buyer is in the room. Answering these questions first turns a general intention to sell into a set of terms an advisor can defend.
Education offers a low-pressure way to start. McLerran & Associates is a PACE-accredited continuing-education provider and hosts the McLerran M&A Summit (October 29–30, 2026), a dental-only event built for owners who have not decided yet. Attendees receive 4 CE credits and a complimentary practice valuation (a $2,500 value). The Summit features presentations, expert panels, and one-on-one CPA sessions. Topics include deal structures, EBITDA, and the DSO and private equity landscape, all before any commitment is made.
If an owner is not ready to sell after the valuation, McLerran will update it for free a year later rather than push them into a deal. The firm focuses on helping owners make a sound decision on timing and path. For guidance on how a dental practice broker and an attorney work together through this process, see dental practice broker vs. attorney: how to use both.
Frequently Asked Questions
Should I Sell To A Private Buyer Or A DSO?
The right path depends on practice size, profitability, and the owner’s personal goals. Smaller premier practices, roughly $1–1.5M in annual revenue, often fit a doctor-to-doctor sale because individual buyers can finance the acquisition and the seller can exit cleanly after a short work-back. The largest practices, those generating $3M or more, often point toward the DSO path, where EBITDA-based multiples and the DSO’s operational infrastructure can produce a higher total outcome. Owners in the $1.5–3M middle can genuinely go either way. Because McLerran & Associates works both markets in roughly equal measure, the firm produces a side-by-side valuation so owners can compare their worth and outcome on each path before deciding instead of guessing based on a single offer.
Why Pay For A Valuation When Other Firms Do It For Free?
A free valuation often functions as a lead magnet and may be a back-of-the-napkin number that does not hold up under buyer scrutiny. When a weak valuation gets picked apart in due diligence, the deal can get re-traded. The buyer then reduces the agreed price after entering exclusivity, when the seller has the least leverage. McLerran & Associates’ CPA-led EBITDA analysis is diligence-grade work done up front, so the number tends to hold when buyers look under the hood and the deal is less likely to be renegotiated down. In one documented case, a free valuation pegged a practice at $2.5M; McLerran valued it at $4.5M and it sold for $5.25M after a competitive process. The firm focuses on selling practices rather than simply listing them.
What Multiple Will My Practice Sell For?
Multiples are driven by fundamentals rather than a fixed table. The larger the practice, the more doctors and expandability, the more durable the revenue, and the higher the EBITDA, the higher the multiple a practice can often command. Specialty plays a role as well. Oral and maxillofacial surgery often commands the highest multiples and remains one of the fastest-consolidating segments, which reflects strong buyer demand, while general dentistry still earns aggressive, near-all-time-high valuations. Key-person dependence, which is how much production relies on the selling dentist personally, along with hygiene revenue as a share of total collections, payer mix, and equipment condition, all move the multiple up or down. A diligence-grade valuation quantifies how these factors apply to a specific practice.
How Do I Know Which DSOs Are The Good Ones?
Vetting DSO buyers is a core part of McLerran & Associates’ job. Of the many DSOs in the market, the firm evaluates which are well-backed, well-run, and have a track record of happy sellers, and has blacklisted those known for creating poor post-close environments, including weaker buyers that emerged when capital flooded the space after COVID. The questions that matter most include whether the whole company is profitable, whether revenue is still growing at the offices it already owns, whether the management team is experienced, and whether the private equity firm backing it has successfully executed this kind of deal before. Owners can benefit from underwriting a DSO the same way they would underwrite any investment, because retained equity in a DSO functions as an investment.
Are DSO Deals All Cash, Or Is There Stock Involved?
Most DSO deals involve a mix of cash and equity. DSO offers typically lead with 60–80% of deal value as cash at close, with the remainder structured as rollover equity and/or an earnout. Rollover equity can be held at the joint-venture level, at the individual practice, with distributions and a higher floor but lower ceiling, or at the holding-company level, where there are no distributions during the hold period but the potential for a much higher return if the DSO recapitalizes at a strong multiple. As much as 40% of a deal can be in equity, which is why McLerran helps owners review the DSO like an investment before accepting any equity component. Earnout payments are contingent on the practice meeting specified financial targets after closing, and the terms of how those targets are measured, and who controls the variables that affect them, are among the most important provisions to negotiate.
Conclusion: Choose Your Dental Practice Transition Option With Full Information
The decision framework in this guide encourages owners to map practice size, timeline, personal goals, and specialty to a likely transition option, then obtain a diligence-grade valuation before choosing a path. The challenge is that owners usually sell once in a lifetime while buyers negotiate every week, and the financial mechanics of valuation, deal structure, tax treatment, and multi-year after-tax outcomes can be complex enough that a single misstep may cost millions.
McLerran & Associates is dental-only, sell-side only, and runs both the private-buyer and DSO paths in roughly equal measure. The firm has completed approximately 2,000 successful practice sales, closed roughly $2 billion in transaction volume, evaluated more than 10,000 practices, and carries over 100 years of collective dental-industry experience across a team of former investment bankers, practice-finance lenders, DSO buyers, and CPAs. Its transaction rate of roughly 85–90%, compared with an industry norm closer to 35–40%, reflects a process built on rigorous valuations, structured competition among vetted buyers, and sell-side advocacy from first conversation to closed deal.
The suggested next steps are concrete. Review your financials, clarify your goals, compare transition paths with a side-by-side valuation, and speak with an advisor who represents only you.
Ready to compare your options with full information? Schedule your discovery call.
